Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ribosomal protein L6 pseudogene 2 (RPL6P2) is a processed pseudogene derived from the ribosomal protein L6 (RPL6) gene. Pseudogenes like RPL6P2 do not encode a functional product and occur due to genomic duplications and retrotransposition events. Unlike the functional RPL6 gene, which encodes a component of the large 60S ribosomal subunit involved in protein synthesis, RPL6P2 lacks coding potential and is not involved in ribosome assembly or cellular function. There is no evidence that RPL6P2 plays a role in disease, drug interaction, or clinical targeting. RPL6P2 is a non-functional processed pseudogene. It is not a protein, not a biological or pharmacological target, and should not be considered in contexts where an active molecule or receptor is required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L6 pseudogene 2 (RPL6P2).